Cancer Treatment and PharmacologyColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and Mutations
Publications
40
Citations
744
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2006
Publication cadence
Publications per year over the last 10 years — averaging 3.2/year recently
Recent publications
- The predictive role of uterine electromyography in delivery before 28 weeks of gestation after transvaginal cervical cerclage
BMC Pregnancy and Childbirth · 2025
- 203 When Rare Meets Rarer: A Mixed Thymoma Uniting the Most Uncommon Thymoma Types
American Journal of Clinical Pathology · 2025
- Uterine Electromyography as a new Predictor of Extremely Preterm Birth: A Multifactorial Model Integrating Clinical and Bioelectrical Parameters
Research Square · 2025
- Nanobody-Based PET Imaging of CD47 Expression in Thyroid Carcinoma
Molecular Pharmaceutics · 2025
- Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study
BMJ · 2024
- Performance of newer myeloma staging systems in a contemporary, large patient cohort
Blood Cancer Journal · 2024
- Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance
Research Square · 2023
- A potential novel biomarker: Comprehensive analysis of prognostic value and immune implication of CES3 in colonic adenocarcinoma
Research Square · 2023
- Supplementary Methods, Tables 1-4, Figures 1-4 from SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both <i>In Vitro</i> and <i>In Vivo</i>
2023
- Supplementary Methods, Tables 1-4, Figures 1-4 from SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both <i>In Vitro</i> and <i>In Vivo</i>
2023
- Data from Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer
2023
- High Body Mass Index Was Associated With Human Epidermal Growth Factor Receptor 2-Positivity, Histological Grade and Disease Progression Differently by Age
World Journal of Oncology · 2023
- Effectiveness and safety of non-vitamin K antagonist oral anticoagulant in the treatment of patients with morbid obesity or high body weight with venous thromboembolism: A meta-analysis
Medicine · 2023
- Association of serum uric acid levels with bone mineral density and the presence of osteoporosis in Chinese patients with Parkinson’s disease: a cross-sectional study
Journal of Bone and Mineral Metabolism · 2023
- The impact of preformed and de novo <scp>HLA‐DP</scp> antibodies in renal transplantation, a meta‐analysis
HLA · 2022
Publishes in
- Research Square×4
- Journal of Clinical Oncology×2
- Medicine×2
- Therapeutic Advances in Medical Oncology×1
- BMJ×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile